Mesentech Inc. announced it raised $3.89 Million in an initial filing from an offering of $7 Million
Apr 14, 2022•about 3 years ago
Amount Raised
$3.89 Million
Round Type
seed
VancouverBiotechnology
Company Information
Company
Mesentech Inc.
Location
2222 HEALTH SCIENCES MALL
Vancouver, Washington, United States
About
Innovative drugs that rebuild bone lost to disease and trauma. Regenerative Medicine to reverse osteoporosis. Mesentech has developed a novel drug conjugate that can deliver bone growing drugs selectively to the bone.